Literature DB >> 15677426

Increased adrenocorticotropin suppression after dexamethasone administration in sexually abused adolescents with posttraumatic stress disorder.

Fabrice Duval1, Marc-Antoine Crocq, Marie-Sabine Guillon, Marie-Claude Mokrani, José Monreal, Paul Bailey, Jean-Paul Macher.   

Abstract

Evidence suggests that individuals with posttraumatic stress disorder (PTSD) have enhanced sensitization of the hypothalamic-pituitary-adrenocortical (HPA) axis. Fourteen adolescent inpatients with DSM-IV PTSD were compared with 14 adolescent hospitalized controls without current axis I diagnoses. All patients were drug-naive. The causative trauma had been sexual abuse in all cases. Dexamethasone, 1 mg orally, was given at 11 PM, 5 days after admission. Baseline blood samples were obtained at 8 AM, and on the following day, adrenocorticotropin (ACTH) and cortisol levels were measured at 8 AM, 4 PM, and 11 PM. Clinical assessment included the Impact of Event Scale, Stanford Acute Stress Reaction Questionnaire, Beck Depression Inventory, and Coping Inventory for Stressful Situations. Post-DST ACTH levels were significantly lower in PTSD than in control adolescents (at 8 AM, P <0.005; at 4 PM, P <0.001; and at 11 PM, P <0.05). In patients, post-DST cortisol levels were reduced but not significantly. No correlations were found between ACTH and cortisol levels and time elapsed since trauma. These results demonstrate that sexually abused adolescents with PTSD show ACTH hypersuppression to DST, suggesting enhanced glucocorticoid receptor sensitivity in the pituitary.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15677426     DOI: 10.1196/annals.1314.036

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  6 in total

1.  Effects of chronic plus acute prolonged stress on measures of coping style, anxiety, and evoked HPA-axis reactivity.

Authors:  Megan K Roth; Brian Bingham; Aparna Shah; Ankur Joshi; Alan Frazer; Randy Strong; David A Morilak
Journal:  Neuropharmacology       Date:  2012-07-25       Impact factor: 5.250

2.  The role of BDNF as a mediator of neuroplasticity in bipolar disorder.

Authors:  Iria Grande; Gabriel Rodrigo Fries; Mauricio Kunz; Flavio Kapczinski
Journal:  Psychiatry Investig       Date:  2010-12-15       Impact factor: 2.505

3.  Altered Pituitary Gland Structure and Function in Posttraumatic Stress Disorder.

Authors:  Odelia Cooper; Vivien Bonert; Franklin Moser; James Mirocha; Shlomo Melmed
Journal:  J Endocr Soc       Date:  2017-04-13

4.  Epigenetic Risk Factors in PTSD and Depression.

Authors:  Florian Joachim Raabe; Dietmar Spengler
Journal:  Front Psychiatry       Date:  2013-08-07       Impact factor: 4.157

5.  Neurobehavioral, neuropathological and biochemical profiles in a novel mouse model of co-morbid post-traumatic stress disorder and mild traumatic brain injury.

Authors:  Joseph O Ojo; M Banks Greenberg; Paige Leary; Benoit Mouzon; Corbin Bachmeier; Michael Mullan; David M Diamond; Fiona Crawford
Journal:  Front Behav Neurosci       Date:  2014-06-23       Impact factor: 3.558

Review 6.  A Comprehensive Overview on Stress Neurobiology: Basic Concepts and Clinical Implications.

Authors:  Lívea Dornela Godoy; Matheus Teixeira Rossignoli; Polianna Delfino-Pereira; Norberto Garcia-Cairasco; Eduardo Henrique de Lima Umeoka
Journal:  Front Behav Neurosci       Date:  2018-07-03       Impact factor: 3.558

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.